How to buy Eton Pharmaceuticals stock

Eton Pharmaceuticals, Inc is a biotechnology business based in the US. Eton Pharmaceuticals shares (ETON) are listed on the NASDAQ and all prices are listed in US Dollars. Eton Pharmaceuticals employs 16 staff and has a trailing 12-month revenue of around 0.00.

Eton Pharmaceuticals share price

Use our graph to track the performance of ETON stocks over time.

Eton Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-04-29.

52-week range	$4.33 - $10.30
50-day moving average	$7.70
200-day moving average	$8.13
Wall St. target price	$13.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-3.07

Buy Eton Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Eton Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Eton Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eton Pharmaceuticals financials

Revenue TTM	$39,000
Gross profit TTM	$-247,000
Return on assets TTM	-78.1%
Return on equity TTM	-213.41%
Profit margin	0%
Book value	$0.64
Market capitalisation	$205.7 million

TTM: trailing 12 months

Shorting Eton Pharmaceuticals shares

There are currently 1.2 million Eton Pharmaceuticals shares held short by investors – that's known as Eton Pharmaceuticals's "short interest". This figure is 2.1% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting Eton Pharmaceuticals shares can be evaluated.

Eton Pharmaceuticals's "short interest ratio" (SIR)

Eton Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eton Pharmaceuticals shares currently shorted divided by the average quantity of Eton Pharmaceuticals shares traded daily (recently around 204267.6222597). Eton Pharmaceuticals's SIR currently stands at 5.93. In other words for every 100,000 Eton Pharmaceuticals shares traded daily on the market, roughly 5930 shares are currently held short.

However Eton Pharmaceuticals's short interest can also be evaluated against the total number of Eton Pharmaceuticals shares, or, against the total number of tradable Eton Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eton Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Eton Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0786% of the tradable shares (for every 100,000 tradable Eton Pharmaceuticals shares, roughly 79 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Eton Pharmaceuticals.

Find out more about how you can short Eton Pharmaceuticals stock.

Eton Pharmaceuticals share dividends

We're not expecting Eton Pharmaceuticals to pay a dividend over the next 12 months.

Eton Pharmaceuticals share price volatility

Over the last 12 months, Eton Pharmaceuticals's shares have ranged in value from as little as $4.325 up to $10.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eton Pharmaceuticals's is 1.192. This would suggest that Eton Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Eton Pharmaceuticals overview

Eton Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. .

Frequently asked questions

• What percentage of Eton Pharmaceuticals is owned by insiders or institutions?

  Currently 27.051% of Eton Pharmaceuticals shares are held by insiders and 35.788% by institutions.

• How many people work for Eton Pharmaceuticals?

  Latest data suggests 16 work at Eton Pharmaceuticals.

• When does the fiscal year end for Eton Pharmaceuticals?

  Eton Pharmaceuticals's fiscal year ends in December.

• Where is Eton Pharmaceuticals based?

  Eton Pharmaceuticals's address is: 21925 West Field Parkway, Deer Park, IL, United States, 60010-7208

• What is Eton Pharmaceuticals's ISIN number?

  Eton Pharmaceuticals's international securities identification number is: US29772L1089

• What is Eton Pharmaceuticals's CUSIP number?

  Eton Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29772L108